U.S., March 17 -- ClinicalTrials.gov registry received information related to the study (NCT07474857) titled 'Anti-HLA Antibodies After Bone Regeneration Surgery' on March 10.
Brief Summary: This study evaluates the occurrence of anti-human leukocyte antigen (anti-HLA) antibodies following bone regeneration procedures performed prior to dental implant therapy. Allogeneic bone grafts are widely used in regenerative oral surgery due to their favorable osteoconductive and osteoinductive properties; however, their use may be associated with the development of anti-HLA antibodies, which could potentially influence graft integration and healing.
Twenty generally healthy adult patients requiring bone augmentation procedures before implant therap...